CYST AND TUBULE FORMATION are the basic building blocks of organogenesis for many branched organs, including the kidney. Due to the complexity of metanephrogenesis (the human kidney is composed of more than 20 cell types and 1 million nephrons) (6, 8) and the transitory nature of cyst and tubule formation, relatively little had been known about cyst and tubule formation before the development of an in vitro assay. Montesano, Schaller, and Orci (5) are well known for designing a very important and widely used in vitro assay in which Madin-Darby canine kidney (MDCK) cells form cysts when placed in a collagen matrix and then undergo tubulogenesis in response to hepatocyte growth factor (HGF). The original paper, published in Cell, described an excellent model of metanephric tubulogenesis, as it simplified a highly complicated process in which the metanephric mesenchyme condenses in response to factors expressed by the ureteric bud and forms a cystlike structure called the renal vesicle. This is followed by the initiation of tubulogenesis and the subsequent formation of "comma-" and "S"-shaped bodies and, ultimately, the nephron unit. This system has been used by many laboratories over the past two decades (2, 3); however, as the authors rightly point out, tubulogenesis from cysts is the reverse of what occurs in polycystic kidney disease (PKD), where cysts form from tubules.
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To remedy the lack of an in vitro model for PKD, the authors have now designed a novel system in which they cultured mouse cortical collecting duct (mCCD) cells and identified a subclone that forms tubules in collagen as opposed to cysts (4). Montesano and colleagues then elegantly showed that elevation of cAMP using forskolin or cholera toxin, or addition of membrane-permeable analogs, such as CPT-cAMP, resulted in rapid and progressive dilation of the tubules, leading to the formation of cysts. Tubule enlargement and cyst formation were prevented by inhibitors of the Na-K-2Cl cotransporter, such as bumetanide, or of the cystic fibrosis transmembrane regulator (CFTR), such as CFTR inhibitor-172. As the authors note, these results support the idea that cAMP plays a key role in renal cystogenesis, at least in part by promoting chloride-driven fluid secretion. These results are especially important as they seem to confirm a leading hypothesis for the mechanism of cystogenesis in PKD, namely, elevation of cAMP and its downstream effector PKA, followed by transcription of the numerous genes involved in proliferation and cyst formation (1, 9) . According to this model, a normally functioning primary cilium senses urinary flow as it is bent and a calcium signal is sent to the inside of the cell (polycystin-2, found on the primary cilium, is a calcium channel) and then amplified by calcium release from the endoplasmic reticulum. The increased intracellular calcium then breaks down cAMP to 5Ј-AMP by activating phosphodiesterase and directly inhibits adenylyl cyclase VI. Adenylyl cyclase VI, whose job it is to convert ATP to cAMP, is, in turn, activated by vasopressin binding to its receptor. A phase III trial in autosomal dominant PKD patients of tolvaptan, a vasopressin receptor antagonist, is now underway based on this model.
Cysts and tubules, while obviously not identical, are topologically quite similar in that they both have an apical membrane that faces the lumen, a lateral surface involved in cell-to-cell contact, and a basal surface interacting with the underlying tissue or extracellular matrix. The main difference between cysts and tubules, then, is the axis of cell division or the "plane of polarity." Planar cell polarity has recently been shown to be centrally involved in PKD (7), and this new in vitro system provides an excellent model in which to study this question. Although Montesano and coworkers (4) did perform initial studies examining the Wnt signaling system (which did not show activation of the ␤-catenin/T cell factor pathway), I think that there is much more work that could be done. For example, the dynamic expression of planar polarity proteins Vangl, Prickle, and Dvl during cystogenesis would be an interesting place to start. This system has the potential to become the premier in vitro system for studying PKD and the factors affecting the axis of cell division, just as the MDCK/ HGF system that the authors previously developed became the premier system for studying in vitro tubulogenesis and kidney development. Sometimes, lightening does strike twice.
